Single agent fluorouracil for first-line treatment of advanced colorectal cancer as standard?
- PMID: 17630019
- DOI: 10.1016/S0140-6736(07)61062-9
Single agent fluorouracil for first-line treatment of advanced colorectal cancer as standard?
Erratum in
- Lancet. 2008 Dec 22;370(9605):2102
Comment in
-
CAIRO and FOCUS.Lancet. 2007 Dec 8;370(9603):1904-5; author reply 1905. doi: 10.1016/S0140-6736(07)61807-8. Lancet. 2007. PMID: 18068509 No abstract available.
Comment on
-
Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial.Lancet. 2007 Jul 14;370(9582):135-142. doi: 10.1016/S0140-6736(07)61086-1. Lancet. 2007. PMID: 17630036 Clinical Trial.
-
Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial.Lancet. 2007 Jul 14;370(9582):143-152. doi: 10.1016/S0140-6736(07)61087-3. Lancet. 2007. PMID: 17630037 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
